Reply to: Quantification of perivascular inflammation does not provide incremental prognostic value over myocardial perfusion imaging and calcium scoring Alexios S. AntonopoulosCharalambos Antoniades Letter to the Editor 04 January 2021 Pages: 1707 - 1708
PSMA-PET: is the time to say goodbye to metabolic radiopharmaceuticals in prostate cancer? Laura EvangelistaPierpaolo Alongi Letter to the Editor 13 March 2021 Pages: 1709 - 1711
Clinical perspectives for the use of total body PET/CT Ronan AbgralDavid BourhisPierre-Yves Salaun Editorial 19 March 2021 Pages: 1712 - 1718
SARS-CoV-2-related thyroid disorders: a synopsis for nuclear medicine thyroidologists Luca GiovanellaRosaria M. RuggeriDesiree Deandreis Editorial 25 March 2021 Pages: 1719 - 1723
Medical imaging in times of pandemic: focus on the cornerstones of successful imaging Roberto C. Delgado BoltonAdriana K. Calapaquí TeránFrancesco Giammarile Editorial 26 March 2021 Pages: 1724 - 1725
NEMA NU2-2012 performance measurements of the United Imaging uPMR790: an integrated PET/MR system Shuguang ChenYushen GuHongcheng Shi Original Article 03 January 2021 Pages: 1726 - 1735
Systematic imaging in medicine: a comprehensive review Kai ZhangYujie SunHong Zhang Review Article 19 November 2020 Pages: 1736 - 1758
[11C]MODAG-001—towards a PET tracer targeting α-synuclein aggregates Laura KueblerSabrina BussKristina Herfert Original Article Open access 28 December 2020 Pages: 1759 - 1772
[18F]-JK-PSMA-7 and [18F]-FDG tumour PET uptake in treated xenograft human prostate cancer model in mice Gaetan Van SimaeysGilles DoumontSerge Goldman Original Article 04 January 2021 Pages: 1773 - 1784
Advanced analytics and artificial intelligence in gastrointestinal cancer: a systematic review of radiomics predicting response to treatment Nina J. WesdorpTessa HellingmanGeert Kazemier Review Article Open access 16 December 2020 Pages: 1785 - 1794
Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI L. PappC. P. SpielvogelM. Hacker Original Article Open access 19 December 2020 Pages: 1795 - 1805
Quantification of perivascular inflammation does not provide incremental prognostic value over myocardial perfusion imaging and calcium scoring Susan BengsAhmed HaiderCatherine Gebhard Short Communication Open access 16 November 2020 Pages: 1806 - 1812
Prognostic value of SPECT myocardial perfusion entropy in high-risk type 2 diabetic patients Loïc DjailebAlexandre SeillerGilles Barone-Rochette Original Article 20 November 2020 Pages: 1813 - 1821
Cardiac transthyretin amyloidosis 99mTc-DPD SPECT correlates with strain echocardiography and biomarkers Viktor LöfbackaJan AxelssonTorbjörn Sundström Original Article Open access 26 December 2020 Pages: 1822 - 1832
A diagnostic strategy for Parkinsonian syndromes using quantitative indices of DAT SPECT and MIBG scintigraphy: an investigation using the classification and regression tree analysis Yu IwabuchiMasashi KameyamaMasahiro Jinzaki Original Article Open access 03 January 2021 Pages: 1833 - 1841
Improved amyloid burden quantification with nonspecific estimates using deep learning Haohui LiuYing-Hwey NaiAnthonin Reilhac Original Article Open access 07 January 2021 Pages: 1842 - 1853
Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG PET-CT and relevance to study interpretation Dan CohenShir Hazut KrauthammerEinat Even-Sapir Original Article Open access 27 March 2021 Pages: 1854 - 1863
Comparison of MRI, [18F]FDG PET/CT, and 99mTc-UBI 29-41 scintigraphy for postoperative spondylodiscitis—a prospective multicenter study Diana PaezMike M. SathekgeGiuliano Mariani Original Article Open access 18 November 2020 Pages: 1864 - 1875
Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis K. S. M. van der GeestG. TregliaO. Gheysens Review Article Open access 28 December 2020 Pages: 1876 - 1889
Structural and metabolic brain abnormalities in COVID-19 patients with sudden loss of smell Maxime NiesenNicola TrottaXavier De Tiège Original Article 04 January 2021 Pages: 1890 - 1901
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of 177Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma Ayca LøndalenJohan BlakkisrudCaroline Stokke Original Article Open access 16 November 2020 Pages: 1902 - 1914
Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancers Sanjana BallalMadhav Prasad YadavChandrasekhar Bal Original Article 26 November 2020 Pages: 1915 - 1931
Interim [18F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma Christos SachpekidisAnnette Kopp-SchneiderAntonia Dimitrakopoulou-Strauss Original Article Open access 18 December 2020 Pages: 1932 - 1943
Role of [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET/CT Liang ZhaoYizhen PangHaojun Chen Original Article 07 January 2021 Pages: 1944 - 1955
Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes Eike SteidlKarl-Josef LangenGabriele D. Maurer Original Article Open access 26 November 2020 Pages: 1956 - 1965
Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer Hui TanXiuli SuiHongcheng Shi Original Article 27 November 2020 Pages: 1966 - 1975
PET/MRI assessment of lung nodules in primary abdominal malignancies: sensitivity and outcome analysis Pierpaolo BiondettiMark G. VangelOnofrio A. Catalano Original Article 07 January 2021 Pages: 1976 - 1986
Uncovering the invisible—prevalence, characteristics, and radiomics feature–based detection of visually undetectable intraprostatic tumor lesions in 68GaPSMA-11 PET images of patients with primary prostate cancer Constantinos ZamboglouAlisa S. BettermannAnca-Ligia Grosu Original Article Open access 18 November 2020 Pages: 1987 - 1997
Predicting tumor response and outcome of second-look surgery with 18F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer Nicolas AidePauline FauchilleFlorence Joly Original Article Open access 21 November 2020 Pages: 1998 - 2008
Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography Mubarik A. ArshadSamuel GitauTara D. Barwick Original Article Open access 11 December 2020 Pages: 2009 - 2023
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy Kerstin MichalskiJuri RufPhilipp E. Hartrampf Original Article Open access 18 December 2020 Pages: 2024 - 2030
18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results L. M. MittlmeierM. UnterrainerM. Staehler Original Article Open access 28 December 2020 Pages: 2031 - 2037
[18F]DCFPyL PET/CT in detection and localization of recurrent prostate cancer following prostatectomy including low PSA < 0.5 ng/mL Elisa PerryArpit TalwarTom R. Sutherland Original Article 05 January 2021 Pages: 2038 - 2046
Whole-body parametric [18F]-FDG PET/CT improves interpretation of a distant lesion as venous embolus in a lung cancer patient Michael MesserliFotis KotasidisIrene A. Burger Image of the Month Open access 15 January 2021 Pages: 2047 - 2048
18F-FDG PET/CT and MRI findings of Shulman syndrome also known as eosinophilic fasciitis Juliette BarletAlexandre VironeFlorent L. Besson Image of the Month 18 January 2021 Pages: 2049 - 2050
[68Ga]Ga-FAPI and [18F]FDG PET/CT images in a patient with juvenile polymyositis Jieling ZhengHuaning ChenWeibing Miao Image of the Month 18 January 2021 Pages: 2051 - 2052
[68Ga]Ga-DOTA-FAPI-04 PET/CT imaging of benign pulmonary solitary fibrous tumour Huipan LiuLin LiuYue Chen Image of the Month 18 January 2021 Pages: 2053 - 2054
68Ga-FAPI outperforms 18F-FDG PET/CT in identifying solitary fibrous tumor Rongxi WangQingxing LiuRuixue Cui Image of the Month 19 January 2021 Pages: 2055 - 2056
The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging Ann-Christin EderMohamed A. OmraneJuri Ruf Image of the Month Open access 23 January 2021 Pages: 2057 - 2058
Physiological FAP-activation in a postpartum woman observed in oncological FAPI-PET/CT Katharina DendlStefan A. KoerberFrederik L. Giesel Image of the Month Open access 04 February 2021 Pages: 2059 - 2061
[18F]FDG -PET/CT uptake reveals a single metastasis inside vertebral hemangioma - Catch me if you scan Yogev CohenAlbert GrinshpunJeremy Godefroy Image of the Month 10 February 2021 Pages: 2062 - 2063
Correction to: 68Ga-FAPI outperforms 18F-FDG PET/CT in identifying solitary fibrous tumor Rongxi WangQingxing LiuRuixue Cui Correction 03 March 2021 Pages: 2064 - 2065
Correction to: [18F]FDG -PET/CT uptake reveals a single metastasis inside vertebral hemangioma, catch me if you scan Yogev CohenAlbert GrinshpunJeremy Godefroy Correction 05 April 2021 Pages: 2066 - 2066